An NYT story blamed leftists for obstructing psychedelic therapy… truth is…
Without the efforts of this “small band of anticapitalist activists,” the authors argue, Lykos Therapeutics’ “$250 million investment” in MDMA-AT may have paid off by being the first psychedelic therapy to get federal approval – potentially establishing the company as a multibillion-dollar enterprise. As a journalist who has followed the psychedelics movement for years and attended hearings…
Recent Comments